MENU
+Compare
NUVB
Stock ticker: NYSE
AS OF
Jul 18, 03:26 PM (EDT)
Price
$2.25
Change
+$0.02 (+0.89%)
Capitalization
762.19M

NUVB Nuvation Bio Forecast, Technical & Fundamental Analysis

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUVB with price predictions
Jul 17, 2025

NUVB saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for NUVB moved out of overbought territory on July 14, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 52 similar instances where the indicator exited the overbought zone. In of the 52 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUVB broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on NUVB as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUVB just turned positive on July 02, 2025. Looking at past instances where NUVB's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

NUVB moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NUVB crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUVB advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.817) is normal, around the industry mean (17.995). P/E Ratio (0.000) is within average values for comparable stocks, (59.169). NUVB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.515). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (60.976) is also within normal values, averaging (275.695).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NUVB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVB is expected to report earnings to rise 4.44% to -16 cents per share on August 06

Nuvation Bio NUVB Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $1.83
The last earnings report on May 07 showed earnings per share of -15 cents, missing the estimate of -15 cents. With 1.53M shares outstanding, the current market capitalization sits at 762.19M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCPIX92.80N/A
N/A
ProFunds UltraSector Health Care Inv
EKBYX14.45N/A
N/A
Allspring Diversified Cap Bldr Inst
MGFLX10.26N/A
N/A
MassMutual Global Adm
ASLGX132.33N/A
N/A
American Century Select R5
VZGRX64.53N/A
N/A
Virtus Zevenbergen Innovative Gr Stk R6

NUVB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+0.45%
BEAM - NUVB
47%
Loosely correlated
+1.89%
XNCR - NUVB
47%
Loosely correlated
+2.72%
DNLI - NUVB
46%
Loosely correlated
-2.29%
ERAS - NUVB
45%
Loosely correlated
+3.47%
KYMR - NUVB
43%
Loosely correlated
+1.85%
More